admin

admin

HLA featured in the Australian Financial Review

  In a major test, HLA and its rival – a massive one in IBM’s Watson – are being trialled by the United States National Cancer Institute. When Professor Jon Patrick began spruiking his digital health start-up to potential investors two years…